{{Rsnum
|rsid=6997709
|Chromosome=8
|position=139167781
|Orientation=plus
|GMAF=0.1869
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 54.0 | 37.2 | 8.8
| HCB | 80.3 | 19.0 | 0.7
| JPT | 89.4 | 10.6 | 0.0
| YRI | 79.6 | 19.0 | 1.4
| ASW | 68.4 | 31.6 | 0.0
| CHB | 80.3 | 19.0 | 0.7
| CHD | 82.6 | 17.4 | 0.0
| GIH | 64.4 | 31.7 | 4.0
| LWK | 76.4 | 20.0 | 3.6
| MEX | 63.8 | 31.0 | 5.2
| MKK | 59.6 | 36.5 | 3.8
| TSI | 51.0 | 42.2 | 6.9
| HapMapRevision=28
}}
[[rs6997709]] has been reported in a large study to be associated with [[high blood pressure]].

The risk allele (oriented to the dbSNP entry) is (G); the odds ratio associated with heterozygotes is 1.20 (CI 0.94-1.52), and for homozygotes, 1.49 (CI 1.18-1.89). {{PMID|17554300|OA=1
}}

In a study of 7,551 Koreans, this SNP was associated with systolic and diastolic blood pressures in a quantitative trait association test but no associations were found using a case-control association test.{{PMID|19424278}}

{{PMID Auto
|PMID=18523456
|Title=Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}